Dr Reddy’s Laboratories Ltd has received USFDA approval for Aspirin and extended-release Dipyridamole capsules. The drug is a therapeutic equivalent generic version of Aggrenox (Aspirin […]
Aurobindo Pharma has received final USFDA approval to manufacture and market Bivalirudin injection, 250 mg/vial. The drug Bivalirudin is a generic equivalent to the reference […]
Unichem Laboratories has received final USFDA approval for its Montelukast chewable tablets used for prevention and treatment of asthma. The product is a generic version […]
Zydus Cadila has received final USFDA approval to market Tadalafil tablets in American markets. The drug Tadalafil is used to erectile dysfunction and enlarged prostrate. […]
Lupin has received USFDA approval to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets in the American market. The drug is a generic version of Bayer […]
Glenmark Pharmaceuticals has received final USFDA for Tacrolimus ointment used for treating atopic dermatitis (eczema). The ointment is a generic version of Protopic ointment, of […]
Strides Shasun has received USFAD approval for Cyproheptadine Hydrochloride tablets, used to relieve such as watery eyes, runny nose, sneezing, hives, and itching. The drug […]
Alembic Pharma has received USFDA approval for its Acyclovir ointment USP, used for the treatment of genital herpes. The ointment is therapeutically equivalent to the […]
Sun Pharmaceutical Industries has received USFDA approval for the drug tildrakizumab-asmn which is used for the treatment of adults with moderate-to-severe plaque psoriasis who are […]
Jubilant Life Sciences has received final USFDA approval for Amantadine Hydrochloride tablets, an anti-viral and anti-Parkinsons drug. The drug is a generic version of Symmetrel […]
Copyright © 2021 | Ibis Research Information Services Pvt Ltd Privacy Policy and Terms of Use